Aliskiren and valsartan combination therapy for the management of hypertension

Overview of attention for article published in Vascular Health and Risk Management, August 2010

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Rationale for nebivolol/valsartan combination for hypertension

Article in Journal of Hypertension (May 2017)

The effects of novokinin, an AT2 agonist, on blood pressure, vascular responses, and levels of ADMA, NADPH oxidase, and Rho kinase in hypertension induced by NOS inhibition and salt

Article in Turkish Journal of Medical Sciences (June 2016)

Two‐Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non‐Interventional Prospective Study

Article in Journal of Clinical Hypertension (November 2015)